Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: bentway who wrote (311311)	11/19/2006 7:26:00 PM
From: combjelly	Respond to of 1574848

"When you do that, they still seem better than the competition." Like Japan. With their stance that Japanese have a unique biochemistry to justify their refusal to approve many drugs that aren't developed by Japanese companies. Or, at least they were doing that 20 years ago.

To: bentway who wrote (311311)	11/19/2006 8:29:27 PM
From: MJ	Read Replies (1) \| Respond to of 1574848

J. Chris One of the reasons that may have happened was public demand to get drugs approved more rapidly. I have dealt with numeous illnesses with friends and family--- always there seem to be drugs/medicines that were in the process of development but not being approved by FDA. Sid Wolf who puts together the Best Pill, Worst PIlls book for the Nader organization-------------suggests that you not be the first to try a new med, give it 2 to 3 years until it's effectiveness and side effects are known in the public market. In other words, if you are amongst the first you are part of the experiment. mj